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Background: Adequate bowel preparation is essential for accurate colonoscopy. Both oral sodium phosphate (NaP) and
polyethylene glycol-based lavage (PEG-ELS) are used predominantly as bowel cleansing modalities. NaP has gained popularity
due to low drinking volume and lower costs. The purpose of this randomized multicenter observer blinded study was to compare
three groups of cleansing (NaP, NaP + sennosides, PEG-ELS + sennosides) in reference to tolerability, acceptance, and cleanliness.
Patient and Methods: 355 outpatients between 18 and 75 years were randomized into three groups (A, B, C) receiving NaP =
A, NaP, and sennosides = B or PEG-ELS and sennosides = C. Gastroenterologists performing colonoscopies were blinded to the
type of preparation. All patients documented tolerance and adverse events. Vital signs, premedication, completeness, discomfort,
and complications were recorded. A quality score (0–4) of cleanliness was generated. Results: The three groups were similar with
regard to age, sex, BMI, indication for colonoscopy, and comorbidity. Drinking volumes (L) (A = 4.33 + 1.2, B = 4.56 + 1.18, C
= 4.93 + 1.71) were in favor of NaP (P = .005). Discomfort from ingested ﬂuid was recorded in A = 39.8% (versus C: P = .015), B
= 46.6% (versus C: P = .147), and C = 54.6%. Diﬀerences in tolerability and acceptance between the three groups were statistically
not signiﬁcant. No diﬀerences in adverse events and the cleanliness eﬀects occurred in the three groups (P = .113). The cleanliness
quality scores 0–2 were calculated in A: 77.7%, B: 86.7%, and C: 85.2%. Conclusions: These data fail to demonstrate signiﬁcant
diﬀerences in tolerability, acceptance, and preparation quality between the three types of bowel preparation for colonoscopy.
Cleansing with NaP was not superior to PEG-ELS.
Copyright © 2008 S. Schanz et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Colonoscopy is performed as a principal diagnostic tool
in most colonic disorders. Adequate bowel preparation
is essential for proper visualization of mucosa. Superior
cleansing minimizes the risks of missed lesions and repeated
procedures, and decreases patients’ discomfort and costs of
colonoscopy [1, 2].
Peroral polyethylene glycol (PEG) solution has been the
cleansingagentmostusedinrecentyears.Thisnondigestible,
nonabsorbable osmotically balanced laxative lavage solution
does not alter ﬂuid and electrolyte balance [3–6]. Despite the
improved tolerance to the two-day standard preparation of
clearliquids,laxatives,andenemas,thelargeﬂuidintakemay
lead to nausea and abdominal discomfort.
Sodium phosphate (NaP), a highly osmotic laxative, has
also proven to be an eﬀective and well-tolerated agent [7].
Because of the small quantity needed, it has become one of
the preferred agents. Over the past decade, numerous studies
have demonstrated that oral NaP is even better tolerated and
results in more eﬀective colon cleansing compared with PEG
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Despite its popularity, NaP generally fails to show better
eﬃcacy than PEG-ELS.
In some less comprehensive studies, PEG-ELS prepara-
tion even yields better results [14–17].
The purpose of this prospective randomized observer-
blinded multicenter study was to compare not only toler-
ability as the primary aim, but also the eﬃcacy and safety
proﬁle of the bowel preparation solely using NaP versus NaP
and PEG in combination with sennosides as an adjunctive
laxative.
2. PATIENTS AND METHODS
A total of 360 patients were recruited during a four-month
period, of which 355 consecutive outpatients aged between
18 and 75 years were included in the study, undergoing
colonoscopy in 5 endoscopy centres after cleansing prepara-
tion. Indications for colonoscopy were history or symptoms
of intestinal complaints, weight loss, anaemia, or control of
persistent diseases. Patients with an urgent indication for
colonoscopy, intolerance to one of the used components,
or insuﬃcient compliance were excluded from the study.
Patients were randomized into three preparation protocols
and analysed for tolerability, eﬃcacy, and safety. They were
instructed to remain on a clear liquid diet for 24 hours
prior to the procedure. According to the type of the study
using well-established routine procedures, for legal reasons
no formal ethical approval was necessary. The study was
conducted in line with the ethical commitments of the
hospital. All patients gave written informed consent. The
study was sponsored by Ferring, Germany, without any
intellectual or substantial input into the study protocol and
analysis of results.
3. BOWEL PREPARATION
3.1. NaP(groupA)
NaP (Fleet Phospho-soda, Ferring, Germany) was adminis-
tered in two doses of 45mL each, containing 10.8g disodium
phosphate dodecahydrate and 24.4g sodium dihydrogen
phosphate dihydrate. According to the protocol, the ﬁrst
dose was given in the evening before the examination
(19:00p.m.), and the second in the morning before the
procedure (7:00a.m.). Each dose was diluted in 120mL of
cold water followed by other 240mL of cold water. The day
before colonoscopy the patient was encouraged to drink at
least 3L or more of clear liquids.
3.2. NaP+sennosides(groupB)
In addition to Group A protocol, sennosides preparation
(X-Prep, Mundipharma, Germany) as a supplemental lax-
ative was given the day before the procedure (14:00p.m.).
One dose of 75mL contains 150mg of standardized
hydroxyanthracene-glycosides(sennosideB).Laxativeeﬀects
start 5–8 hours after the intake. In addition, the patients had
todrinkatleastaglass(240mL)ofcoldwater.Thedaybefore
Table 1: Cleanliness quality score of the blinded endoscopist.
0 Dry colon, no solid faeces
1 Only transparent ﬂuid
2 Fluid faeces
3 Small amount of solid faeces, ≥90% of the mucosa visible
4 Solid faeces, <90% of the mucosa visible
colonoscopy the patient was encouraged to drink at least 3L
or more of clear liquids within the following 4 hours.
3.3. PEG-ELSandsennosides(groupC)
Patients receiving PEG-ELS were instructed to remain on
clear liquids (3-4L) after a light meal at 13:00p.m. the
day before the examination. One dose of sennosides (X-
Prep) was administered at 14:00p.m.. Before 7:00a.m. on
the day of the procedure the patients were to drink 4
sachets of PEG-ELS (Klean-Prep) diluted in 1L of water
per dose, containing 68.96g of PEG 3350 with potassium
chloride, sodium chloride, sodium hydrogen carbonate, and
sodium sulphate. The intake of PEG-ELS (250mL each
within 10–15minutes) before colonoscopy was continued
until cleanliness of faeces was proven or a maximum volume
of 4L was consumed.
Prior to the examination, patients rated their tolerability
of the drinking volume, and the entire preparation received
a rating of good, moderate, or poor. Adverse events were
recorded according to GCP in detail in the case-report form
and carefully monitored by the trial investigator and the
sponsor. They were also evaluated (none, mild, moderate,
and severe) by each patient. All recorded adverse events were
speciﬁed and listed in the ﬁnal report.
Demographic data, comorbidity, and medication of the
study population were also documented before allocation
to the corresponding preparation regimen according to the
random list.
Each colonoscopy was performed by an experienced
endoscopist blinded with regard to the preparation protocol.
Commencement of the endoscopic procedure was between
11:00a.m. and 1:00p.m. The acquisition of information
about bowel cleansing methods was not permitted. Pre-
medication, vital signs, and complications during the pro-
cedure were documented including reasons for incomplete
endoscopy. Discomfort of the ingested ﬂuids was qualiﬁed
in a verbal rating scale as “no, slight, moderate, or strong
discomfort.” The quality of cleanliness and visibility of the
colonic mucosa were scored according to a modiﬁed ﬁve-
level rating scale used in prior clinical studies [7–9, 17–19]
(see Table 1).
3.4. Statistics
Statistical analysis was based on group randomisation to
enable allocation of each consecutive patient to the predeter-
mined random list. Computer-generated randomisation lists
were applied to each participating centre. Each working day
was assigned to one treatment group, resulting in the sameS. Schanz et al. 3
preparation protocol for all patients studied at a particular
day. Comparison of the three preparation modalities A, B,
and C was realized by analysis of variance (ANOVA), t-
test, U-test, χ2 (chi-square) test for testing each regimen
pair, Kruskal-Wallis test (K-W test), Mantel-Haenszel X2 test
for additional pair comparison (X2
MH: test of linear relation
betweencolumnsofcross-tables),analysisoffactors,andtest
of equivalence for responder rates. All tests were conducted
two-sided. P<. 05 was considered to demonstrate statistical
signiﬁcance or equivalence, and respective numbers were
given as mean ± standard deviation. The primary objective
was to demonstrate a 20% superior tolerability of the
treatment arm A. If signiﬁcant, equivalent eﬃcacy of NaP
+ sennosides (B) compared with PEG-ELS + sennosides (C)
w a st e s t e d( g o o da n de x c e l l e n te ﬀects) on the basis of a level
of equivalence of 15% and a success rate of at least 85% of
the standard which was deﬁned hypothetically as PEG-ELS
+ sennosides. If signiﬁcant, equivalent eﬃcacy of NaP (A)
compared with PEG-ELS + sennosides (C) was tested on the
basis of a level of equivalence of 15% and a success rate of at
least 85% of the standard. Accordingly, group sizes of at least
107 patients were calculated to test superiority with a power
of1−β = 0.80.Fordatamanagementandstatisticalanalyses,
the SAS software was used.
4. RESULTS
355 out of 360 patients between 17 and 82 years (median
age of 59 years) participated in the study with an indication
for a complete colonoscopy. Comorbidity was present in
194 patients (54.6%), mostly with cardiovascular diseases
(23.1%)followedbydiseasesofgastrointestinaltract(16.9%)
and endocrine or metabolic abnormalities (13.0%). Medica-
tionofconcomitantdiseaseswasdocumentedin174patients
(49%). Characteristics of the patients randomized into the
three groups (A, B, and C) are outlined in Table 2.
The three groups were similar with regard to age, BMI,
indication for colonoscopy, and comorbidities. Compliance
with the cleansing protocol was also comparable between
groups A (99.2%), B (97.7%), and C (95.7%). All patients
were examined in 5 centres. The distribution of patients to
each centre (C) was as follows: C1: n = 73, C2: n = 69, C3:
n = 36, C4: n = 111, and C5: n = 67. The reason for the
disproportion of patients in the groups A, B, and C was due
to lower numbers of colonoscopies in centres 3 and 4 on the
examination days randomized to C.
The total volume of administered ﬂuids for bowel
cleansing in the three groups varied (A: 4.33L, B: 4.56L, and
C: 4.93L; ANOVA: P = .005, Kruskal-Wallis: P = .015).
Discomfort according to the verbal rating scale showed a
signiﬁcant diﬀerence between Group A and Group C in pair
analysis (see Figure 1).
All relevant symptoms during preparation were proto-
colled (nausea, vomiting, abdominal pain or bloating, anal
irritation, fatigue, sleep disorder, hunger, weakness, chest
pain, chills). Factor analysis showed heterogeneity between
the three groups without relevant diﬀerences (see Figure 2).
Subgroup analyses showed a higher proportion of patients
(>70 years) with nausea and vomiting (nausea: 16 versus 9
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Figure 1: Percentages of patients with (slight to strong) or without
discomfort of ingested liquids (X2 test: P = .015).
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Figure 2: Proﬁle of symptoms during bowel preparation in the
three groups (%).
patients of >70 years, 41 versus 67 patients of <70 years (K-
W test: P =.004); vomiting: 9 versus 16 patients of >70 years,
14 versus 94 patients of <70 years (K-W test: P = .012)).
No signiﬁcant diﬀerence in global tolerability of each
preparation regimen could be ascertained (see Figure 3).
Complete examination of the colon was possible in
94.9% of the patients. Premedication, vital signs, and pain4 Diagnostic and Therapeutic Endoscopy
Table 2: Characteristics of the patients separated by the cleansing protocol (A, B, and C).
ABC T o t a l
Number 128 133 94 355
Age (median) 61 59 57.5 59
BMI (kg/m2) 25.1 24.9 24.9 25
Indication for colonoscopy
Abdominal symptoms 38.3% 40.6% 38.3% 139 (39.2%)
Other 7.8% 9.8% 7.4% 30 (8.5%)
Suspected colonic disorder 23.4% 24.1% 20.2% 90 (25.4%)
Control of colonic disease 32% 24.1% 20.2% 92 (25.9%)
Aggravation of colonic disease 5.5% 8.3% 8.5% 26 (7.3%)
Comorbidities 57.8% 49.6% 57.4% 194 (54.6%)
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Figure 3: Tolerability of the three preparation modalities received a
rating of good, moderate, or poor.
before and during colonoscopy were registered and were
similar in the three groups. The assessment of the cleanliness
quality was evaluable in 337 patients in which complete
colonoscopy could be achieved. Cleansing eﬃcacy was high
in all three groups, and there was no statistical diﬀerence.
Group C (PEG-ELS + sennosides) tended towards a better
responseintheanalysisofdetailswithregardtoallscores(see
Figure 4).Theratesofgoodandverygoodcleanlinessquality
were 77.7% in Group A, 86.7% in Group B, and 85.2% in
G r o u pC( P = .135 in X2 test) (A versus B: P = .062, A
versus C: P = .171, B versus C: P = .755).
Acceptance was high in all groups. Similar proportions
of patients were reported to refuse repetition of the same
preparation regimen: Group A = 14.8%, Group B = 18.5%,
and Group C = 17% (X2 test: P = .737). If there is alternative
preparation oﬀered for colonoscopy, patients would prefer
another protocol in A: 30.2%, B: 30%, and C: 37.2% (X2 test:
P = .445).
5. DISCUSSION
Colonoscopy is an important tool for the diagnosis and
follow-up of colonic disorders and the prevention of neo-
plasms. There is an ongoing search for the ideal cleansing
preparation, aiming at better patient compliance, shorter
colonic preparation time, and better cleansing eﬀects. Con-
sumption of a large amount of ﬂuid is frequently associated
with poor patient tolerance. It might therefore be expected
that a decrease in volume could lead to a better acceptability.
In the present study, bowel cleansing preparation with
NaP with or without sennosides was compared to a
PEG electrolyte solution with sodium sulphate (PEG-ELS)
in combination with sennosides in terms of tolerability,
patient acceptance, and bowel cleanliness. The investigation
included a considerable number of patients. The diﬀerences
in the sizes of the three treatment arms are due to the
randomisation procedure, and may not very likely inﬂuence
outcomes in the view of very similar baseline characteristics.
Our results of the present study indicate that all three
regimens showed a good tolerability with a trend towards
PEG-ELS,butthisdiﬀerencedidnotreachalevelofstatistical
signiﬁcance. As demonstrated in other studies, NaP was
not better tolerated although the ingested volume of liquids
was signiﬁcantly lower (medium: 14%) in the NaP group.
Subgroup analysis in consideration of age however showed
signiﬁcantly more side eﬀects in patients over 70 years like
nausea, vomiting, and abdominal pain in Group B (NaP +
sennosides). Dizziness and presyncope as symptoms caused
by volume depletion and hyperphosphatemia were not pre-
dominant in theNaP regimens, whichis concordantwiththe
literature[20].Vomitingandabdominaldiscomfortreported
as frequent side eﬀects of PEG-ELS with a better tolerance of
NaP [21] were not increased in the PEG-ELS group.
Acceptance of the three preparation protocols was simi-
lar. Less than 20% of each group would not like to repeat the
same regimen for bowel cleansing. Also similar proportions
of patients would prefer another cleansing solution for the
next colonoscopy with an insigniﬁcant trend towards NaP
protocols. Considerably better results in acceptance were
reported in literature when NaP was compared with PEG
solutions [8–10, 21–23].
Regarding the cleanliness eﬀects, all three preparation
protocols were highly eﬀective with a very good or good
response between 77.7% and 86.7%. Overall cleanliness of
the colon was assessed without specifying the cleansing
eﬀects in the diﬀerent bowel segments. According to aS. Schanz et al. 5
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Figure 4: Cleanliness responses to bowel preparation as a percent-
age between the three groups. Cleansing rating includes excellent
and good (P = .013).
worst-case analysis, solid faeces in any of the segments was
judged as cleanliness score 4 and transparent ﬂuid in all
segments as good (score 1). In contrast, Ell et al. [27]a n a l -
ysed the eﬀects of bowel preparation of diﬀerent segments,
which gives some additional information. Because of the
high number of patients, we chose a less complex protocol,
also omitting systematic videotaping.
Although there was a trend towards better cleanliness
with PEG-ELS plus sennosides, the diﬀerences showed no
statistical signiﬁcance. Similar responses were reported by
others [18, 22–26].
It is widely established to perform bowel cleansing with
PEG-ELS within 2 consecutive days. Because of adding
sennosides to the preparation protocol taken the day before
the examination, there was no distribution of the amount of
PEG-ELSontwodayswithanovernightpause.Hence,inour
protocol the whole PEG-ELS dose was taken over at least 4–
6 hours on the day of the examination under strict control
of the unblinded endoscopy assistant nurses of each centre.
Then colonoscopy was commenced.
In a recent study by Ell et al. [27], the PEG-ELS
(with sodium sulphate) treatment group demonstrated the
optimal cleansing quality in all colon segments compared
to PEG-ELS (without sodium sulphate) and NaP. No details
were given on the amount of liquids taken together with
each preparation regimen, which in our opinion plays an
important role in the NaP cleansing. Furthermore, most of
the examined subjects were inpatients (86%)—a treatment
group with generally more severe illnesses or at least more
severe comorbidity which may aﬀect bowel preparation.
Therefore, it cannot be compared with our treatment group
made up exclusively of outpatients. PEG-ELS doses were
administered in two portions on the day before and the day
of the examination, which might be an advantage referring
to cleanliness of proximal colonic segments [19].
Despite the administration in a two-step procedure with
an overnight pause, NaP showed no better results than
PEG-ELS plus sennosides as in the study of Frommer [10].
Colonoscopy was performed at the earliest 3-4 hours after
the second dose of NaP.
The combination of NaP with sennosides, a commonly
used laxative to optimize bowel preparation for diagnos-
tic procedures [28], produces a slightly better cleanliness
response than NaP alone. But this minor synergistic eﬀect
does not reach statistical signiﬁcance. On the other hand,
there was a tendency towards more side eﬀects,as mentioned
above.
A meta-analysis of the trials comparing NaP with PEG
solutions concluded that oral NaP was better tolerated by
patients and was at least as eﬃcacious [29].
But heterogeneous groups of patients, outpatients, and
inpatients and diﬀerent protocols were mixed up, which
limits the conclusion.
Each preparation protocol was carried out according
to the dosing instructions recommended for afternoon
colonoscopies. Being consistent with the recommendation of
theASGE,patientswithsevererenalinsuﬃciencyorunstable
cardiac diseases were excluded from the study [30].
6. CONCLUSION
In conclusion, tolerability, acceptance, and the eﬀectiveness
ofthebowelcleansingregimensforelectivecolonoscopywith
two-dose,low-volumeNaPand4LPEG-ELSplussennosides
werecomparable.Sennosidesasadjunctivelaxativehaveonly
minor synergistic eﬀects when added to NaP, and cannot be
recommended for routine endoscopy.
There are still conﬂicting data regarding the optimal
bowel preparation for colonoscopy. This study was carried
out to compare the tolerability, safety, and eﬃcacy of three
(two) widely used bowel lavage solutions in a large cohort
of outpatients. Tolerability and safety were evaluated by
means of a symptom questionnaire completed by each
patient before the procedure. The scoring of cleanliness
was performed during each examination by the blinded
endoscopist. The treatment groups were comparable with
regard to the baseline characteristics.
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